Trials / Not Yet Recruiting
Not Yet RecruitingNCT07234318
Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears
Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The FOCUS study aims to evaluate the clinical efficacy of 0.1% cyclosporine eye drops solution (Vevizye®, Laboratoires THEA) in patients with moderate to severe dry eye disease characterized by ocular surface inflammation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclosporin | This medicinal product contains cyclosporine 0.1% as an active ingredient and pefluorobutylpentane as vehicle. |
Timeline
- Start date
- 2025-12-15
- Primary completion
- 2026-03-15
- Completion
- 2026-06-30
- First posted
- 2025-11-18
- Last updated
- 2025-11-18
Source: ClinicalTrials.gov record NCT07234318. Inclusion in this directory is not an endorsement.